| Pfizer AG - Caverject 20 ug, Injektionspräparat |
| 52510 | | 03 | | Caverject 20 ug | | Injektionspräparat | | G04BE01 | | Alprostadil | | 30.04.2013 | | |
|
| Composition |
| Praeparatio cryodesiccata: alprostadilum 20 µg, lactosum monohydricum, alfadexum, natrii citras dihydricus, acidum hydrochloridum aut natrii hydroxidum, pro vitro.
Solvens: conserv.: alcohol benzylicus 8.4 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. |
| Packungsbestandteile |
| Praeparatio cryodesiccata: | | Injection preparation | | | | | | Active Agent | Dose |
|---|
| Alprostadil | 20 µg |
| | | | Inactive agents |
|---|
| Acidum Hydrochloridum aut Natrii Hydroxidum | | Alfadexum | | Lactose Monohydrate | | Natrii Citras Dihydricus |
|
| Solvens | | Injection preparation | | | | | | | | | Inactive agents | Dose | additional_information |
|---|
| Alcohol Benzylicus | 8.4 mg/ml | conserv. |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 105 | Durchstechflasche(n) | PR | PR | A | | Yes |
|
